Neoplasms, Ovarian Completed Phase 3 Trials for Paclitaxel (DB01229)

Also known as: Ovarian neoplasm / Ovarian Neoplasms / Neoplasms,Ovarian / Ovarian neoplasia / Ovarian tumor / Ovarian neoplasm NOS

IndicationStatusPhase
DBCOND0030336 (Neoplasms, Ovarian)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01015118LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian CancerTreatment
NCT00191646An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior ChemotherapyTreatment